Putnam FL Investment Management Co. purchased a new position in Danaher Co. (NYSE:DHR) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,260 shares of the conglomerate’s stock, valued at approximately $210,000.
Several other large investors have also added to or reduced their stakes in DHR. National Asset Management Inc. lifted its holdings in shares of Danaher by 0.4% in the second quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock valued at $318,000 after buying an additional 14 shares during the period. Simmons Bank lifted its holdings in shares of Danaher by 0.4% in the second quarter. Simmons Bank now owns 7,160 shares of the conglomerate’s stock valued at $604,000 after buying an additional 26 shares during the period. Horizon Investments LLC lifted its holdings in shares of Danaher by 0.4% in the second quarter. Horizon Investments LLC now owns 7,828 shares of the conglomerate’s stock valued at $648,000 after buying an additional 28 shares during the period. WESPAC Advisors SoCal LLC lifted its holdings in shares of Danaher by 1.2% in the second quarter. WESPAC Advisors SoCal LLC now owns 4,060 shares of the conglomerate’s stock valued at $342,000 after buying an additional 50 shares during the period. Finally, TCI Wealth Advisors Inc. lifted its holdings in shares of Danaher by 1.0% in the second quarter. TCI Wealth Advisors Inc. now owns 5,595 shares of the conglomerate’s stock valued at $472,000 after buying an additional 54 shares during the period. 76.19% of the stock is owned by institutional investors.
Danaher Co. (NYSE DHR) opened at $94.46 on Friday. The firm has a market capitalization of $64,198.66, a price-to-earnings ratio of 26.76, a P/E/G ratio of 1.94 and a beta of 1.04. Danaher Co. has a 52-week low of $78.97 and a 52-week high of $104.82. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39.
The firm also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Friday, December 29th were given a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a yield of 0.59%. The ex-dividend date was Thursday, December 28th. Danaher’s payout ratio is 15.86%.
In related news, EVP William K. Daniel sold 131,066 shares of the company’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $102.05, for a total transaction of $13,375,285.30. Following the transaction, the executive vice president now directly owns 270,523 shares of the company’s stock, valued at $27,606,872.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Daniel L. Comas sold 62,989 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $101.96, for a total value of $6,422,358.44. Following the transaction, the chief financial officer now directly owns 227,805 shares in the company, valued at $23,226,997.80. The disclosure for this sale can be found here. Insiders have sold 274,913 shares of company stock worth $27,729,293 over the last three months. 12.20% of the stock is owned by insiders.
Several analysts have recently weighed in on the company. Robert W. Baird restated a “buy” rating on shares of Danaher in a report on Friday, January 12th. Credit Suisse Group upped their target price on Danaher from $99.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Stifel Nicolaus reaffirmed a “buy” rating and set a $110.00 target price on shares of Danaher in a report on Friday, January 19th. Finally, Evercore ISI began coverage on Danaher in a report on Wednesday, January 3rd. They set an “outperform” rating for the company. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $100.13.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.